MedTrace Logo

Effectiveness of US-Guided PCNL Different Positions in Renal Stones Treatment

NCT05855057 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 123

Last updated 2023-05-11

No results posted yet for this study

Summary

The aim of this study is to compare the effectiveness of Ultrasound-Guided Percutaneous nephrolithotomyin different positions supine, prone positions and flank suspend supine position in renal stones treatment.

Conditions

  • Percutaneous Nephrolithotomy
  • Renal Stones
  • Ultrasound Therapy; Complications

Interventions

PROCEDURE

Flank suspended supine position percutaneous nephrolithotomy

The patients will be placed in the supine position with the shoulder and the buttock will be raised by a 3-l bag of water suspending the flank of the affected side. The body contour will be aligned to the edge of the table. The operating table will be adjusted to the jack knife position, with the tip of the lower part of the table will be slightly lowered. The leg of the affected side of the patent will be straightened dorsally flexed and slightly inner rotated, with the knee of the other side will be flexed. The patients will be then immobilized at the chest and the pelvis with two adherent tapes which crossed each other at the abdomen to form a 'V' shape.

PROCEDURE

Supine percutaneous nephrolithotomy group

The patient will remain in the supine position, with the side of interest at the edge of the table, with a small cushion placed under the flank to elevate it 15-20°.

PROCEDURE

Prone percutaneous nephrolithotomy group

Prone percutaneous nephrolithotomy. The prone position (PRON) technique followed these classic steps: patients will be placed in a lithotomy position and a ureteral catheter will be inserted through a rigid cystoscope to perform a retrograde pyelogram. The ureteral catheter will be fixed to a Foley catheter, and then the patient will be repositioned to the prone position with pads under their shoulders.

Sponsors & Collaborators

  • Benha University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-20
Primary Completion
2022-01-20
Completion
2022-01-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05855057 on ClinicalTrials.gov